If the pathway maintains the same relative expression of CYP7B1 as in NAFLD-NASH stages, then the production of oxysterols to fuel tumor proliferation is more likely. This evidence concerns the gene CYP7B1 and metabolic dysfunction-associated steatotic liver disease.